Pilocarpine is a medicine used to treat glaucoma, which is a condition that can damage your eyes. It works by increasing the fluid drainage in your eye, helping to lower the pressure inside. It's often available as eye drops.
Every report comes from a Lived member, sent anonymously.
Have you tried Pilocarpine for Mouth Dryness?
Pilocarpine is a prescription medicine that comes in two quite different forms. As a tablet, sold as Salagen and as generics, it treats dry mouth in two groups of people: those whose salivary glands were damaged by radiation therapy for head and neck cancer, and those with Sjögren's syndrome, an autoimmune condition that damages the glands that make saliva and tears. Some specialists also try the tablets for dry eyes in Sjögren's. As eye drops, pilocarpine has a long history in glaucoma care. Drops in 1%, 2% and 4% strengths (Isopto Carpine and generics) lower the pressure inside the eye in open-angle glaucoma and ocular hypertension (raised eye pressure without nerve damage yet). Eye doctors also use them during a sudden attack of angle-closure glaucoma (a form in which the iris blocks the eye's drainage angle, causing a rapid rise in pressure) and around some laser procedures. A low-strength drop, Qlosi (0.4%), is approved for adults with presbyopia, the gradual, age-related loss of the eye's ability to focus up close. Vuity, an earlier presbyopia drop, is no longer marketed in the US. The tablets and the drops are not interchangeable. Their strengths, schedules and side effects differ, so this page notes which form each point applies to.
Pilocarpine acts like acetylcholine, a chemical messenger the nervous system uses to switch on glands and certain muscles. It binds directly to that messenger's receptors, called muscarinic receptors. Taken by mouth, it prompts the salivary glands to make more saliva. The effect starts about 20 minutes after a dose, peaks at about an hour and lasts 3 to 5 hours. It can only stimulate gland tissue that still works, which is one reason results vary after radiation. Because the tablet reaches the whole body, it also stimulates sweat glands, tear glands and the bladder, which explains its most common side effects. In the eye, pilocarpine tightens two muscles. Contracting the ciliary muscle, which normally adjusts focus, pulls open the drainage meshwork at the front of the eye so fluid flows out more easily and pressure falls. Contracting the ring muscle of the iris makes the pupil smaller. In angle-closure glaucoma, a smaller pupil draws the iris away from the blocked drainage angle. In presbyopia, a smaller pupil increases the depth of focus, so nearby print looks sharper while some response to light is kept.
For dry mouth after radiation, tablets usually start at 5 mg three times a day. The prescriber may raise the dose according to benefit and side effects, up to 10 mg in any single dose. For Sjögren's, the usual dose is 5 mg four times a day. People with moderate liver disease start at a lower dose, and the tablets are not recommended with severe liver disease. Glaucoma drops are used up to four times a day, and people new to pilocarpine usually start at 1% because higher strengths are hard to tolerate at first. The eye doctor may suggest punctal occlusion: gently pressing the inner corner of the eye for 2 minutes after the drop, which keeps more medicine in the eye and less in the bloodstream. Qlosi is one drop in each eye, used daily or only when needed. A second drop 2 to 3 hours after the first extends the effect, with no more than two doses a day. Each single-use vial is thrown away after use, and the tip should not touch the eye or any surface. With any pilocarpine drop, remove contact lenses first and wait 10 minutes before putting them back in. If you use other eye medicines, leave at least 5 minutes between them.
Tablet side effects come from pilocarpine stimulating glands throughout the body. Sweating is the most common, and it is the side effect that most often leads people to stop. Flushing, chills, needing to urinate more often, nausea, runny nose and dizziness are also common, and they become more frequent at higher doses. In the Sjögren's trials, older adults had more urinary frequency, diarrhea and dizziness than younger people. If heavy sweating continues and you cannot drink enough to keep up, contact the prescriber, because dehydration can develop. Eye drops more often cause brow ache or headache, eye irritation or pain, and blurred, dim or unsteady vision. With Qlosi, stinging when the drop goes in and headache were the most common effects in trials, and most were mild and short-lived. Every form of pilocarpine can blur or darken vision, particularly in dim light. Take extra care driving at night, and do not drive or operate machinery while your vision is not clear. Rarely, pilocarpine eye drops have been linked with retinal detachment, in which the light-sensing layer at the back of the eye pulls away. The risk is higher in people who already have retinal disease. Sudden flashes of light, a burst of new floaters or loss of vision need immediate medical care.
Pilocarpine tablets should not be used by people with uncontrolled asthma, because pilocarpine narrows the airways and increases mucus. They are also avoided when a smaller pupil would be harmful, as in acute iritis (inflammation of the colored part of the eye) or angle-closure glaucoma. People with controlled asthma, chronic obstructive pulmonary disease (COPD) or chronic bronchitis, significant heart disease, gallstones or other gallbladder disease, or kidney stones need closer supervision, since pilocarpine can affect heart rate, blood pressure and the muscles of the airways, bile ducts and urinary tract. Beta-blockers, medicines used for blood pressure and heart conditions, can combine with pilocarpine tablets to disturb the heart's electrical rhythm. Medicines with anticholinergic effects, such as atropine or the inhaled lung medicine ipratropium, work in the opposite direction, so each can blunt the other. Medicines that stimulate the same receptors add to pilocarpine's effects, which can mean more sweating, stomach upset or a slower heart rate. Examples are cevimeline (Evoxac), another dry-mouth medicine for Sjögren's, and bethanechol, a medicine that helps the bladder empty. Pilocarpine eye drops are not recommended while iritis is active, because the iris can stick to the lens. In children with primary congenital glaucoma, the drops have occasionally raised eye pressure instead of lowering it. Pilocarpine has not been well studied in pregnancy. Very high oral doses harmed developing young in animal studies, so the tablets are used in pregnancy only when the benefit seems to justify the risk.
For dry mouth, a tablet starts working within about 20 minutes, and some people notice relief early on. After radiation therapy, though, it can take up to 12 weeks of steady use to know whether it will help. Benefit depends on some saliva-producing tissue remaining, but in trials even people with no measurable saliva flow at the start reported less dryness. In Sjögren's studies, the benefit was established by 6 weeks. Because side effects rise with dose, the prescriber aims for the lowest dose that gives useful relief. Before starting pilocarpine eye drops for glaucoma, an examination of the retina is advised. Eye pressure is then rechecked at follow-up visits, and the strength and number of daily drops are adjusted to the pressure and to how the eye responds. Presbyopia drops begin to work in about 20 minutes, and with a second drop the effect can last up to about 8 hours before it wears off. In the two-week trials of Qlosi, roughly 40 to 50 percent of users could read at least three more lines on a near-vision chart, compared with about 15 to 20 percent using a placebo drop. The drops do not work for everyone, and blurring or dimness in low light is part of the trade-off.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Pilocarpine, what you've noticed, or ask the community a question.